Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,418.66
    +689.62 (+1.39%)
     
  • CMC Crypto 200

    1,393.58
    -2.96 (-0.21%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

NBPE Announces February Monthly NAV Estimate



THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

NBPE Announces February Monthly NAV Estimate

20 March 2024

NB Private Equity Partners (NBPE), the $1.3bn, FTSE 250, listed private equity investment company managed by Neuberger Berman, today announces its 29 February 2024 monthly NAV estimate.

NAV Highlights (29 February 2024)

  • NAV per share was $27.68 (£21.88), an increase of 0.7% in the month

  • Performance driven by increase in private valuations and quoted holdings, offset by negative foreign exchange adjustments

  • $13 million new investment in U.S. healthcare business, Zeus

  • 105,848 shares repurchased during the month, accretive to NAV per share by $0.01

  • First half 2024 dividend of $22 million paid on 29 February 2024

  • $352 million of available liquidity at 29 February 2024

  • 45% of the portfolio’s valuations at 30 September 2023. NBPE expects to issue its 2023 annual financial report in April 2024; Q4 2023 valuation information will be incorporated into future monthly NAV estimates as information is received over the coming weeks

As of 29 February 2024

YTD

1 Year

3 years

5 years

10 years

NAV TR (USD)*
Annualised

0.3%

1.9%

37.6%
11.2%

81.9%
12.7%

199.6%
11.6%

MSCI World TR (USD)*
Annualised

5.6%

25.6%

33.5%
10.1%

78.0%
12.2%

151.1%
9.6%

 

 

 

 

 

 

Share price TR (GBP)*
Annualised

0.6%

2.7%

57.6%
16.4%

84.6%
13.0%

301.7%
14.9%

FTSE All-Share TR (GBP)*
Annualised

(1.1%)

0.6%

25.2%
7.8%

27.7%
5.0%

63.0%
5.0%

*Reflects cumulative returns over the time periods shown and are not annualised.

ADVERTISEMENT

Portfolio Update to 29 February 2024

NAV performance during the month driven by:

  • 0.7% NAV increase ($8 million) from the receipt of additional private company valuation information

  • 0.3% NAV increase ($3 million) from the value of quoted holdings (which now constitute 10% of portfolio fair value)

  • 0.1% NAV decrease ($1 million) from negative FX movements

  • 0.2% NAV decrease ($3 million) attributable to expense accruals and changes in the Zero Dividend Preference share (ZDP) liability

Realisations from the portfolio continue in 2024

  • $38 million of realisations received year to date, consisting primarily of the previously announced sales of FV Hospital and Melissa & Doug as well as realisations from legacy income investments, which now represent 6% of the overall portfolio (3% pro forma for Cotiviti realisation)

  • $51 million of additional expected realisations1

  • Announced recapitalisation of Cotiviti expected to close in the second quarter of 2024

  • Sale of Safefleet

  • In addition, a take private transaction for Agiliti was announced during the month, which will result in the company returning to a private holding. Pro forma for the take private of Agiliti, NBPE’s public investments would represent 9% of the portfolio

$44m invested year to date and one new investment in February 2024

  • $13 million invested into a new investment in February 2024 in a U.S. healthcare business, Zeus, a leader in the design and manufacturing of mission-critical components for medical devices used in minimally invasive life-saving procedures. The investment was made alongside EQT, who will support Zeus’ growth with investments in additional capacity, R&D and operational excellence to support the rapidly growing medical fields that leverage minimally invasive technologies

  • In total, $44 million of new and follow on investments year to date

Well positioned to take advantage of investment opportunities with significant available liquidity at 29 February 2024

  • $352 million of available liquidity

– $210 million undrawn credit line and $142 million of cash / liquid investments

Portfolio Valuation

The fair value of NBPE’s portfolio as of 29 February 2024 was based on the following information:

  • 14% of the portfolio was valued as of 29 February 2024

    • 10% in public securities

    • 4% in private direct investments

  • 2% of the portfolio was valued as of 31 January 2024

    • 2% in private direct investments

  • 39% of the portfolio was valued as of 31 December 2023

    • 38% in private direct investments

    • 1% in private fund investments

  • 45% of the portfolio was valued as of 30 September 2023

    • 45% in private direct investments

For further information, please contact:

NBPE Investor Relations         +44 20 3214 9002
Luke Mason                              NBPrivateMarketsIR@nb.com 

Kaso Legg Communications   +44 (0)20 3995 6673

Charles Gorman                        nbpe@kl-communications.com
Luke Dampier
Charlotte Francis

Supplementary Information (as at 29 February 2024)

Company Name

Vintage

Lead Sponsor

Sector

Fair Value ($m)

% of FV

Action

2020

3i

Consumer

83.9

6.3%

Osaic

2019

Reverence Capital

Financial Services

56.5

4.2%

Solenis

2021

Platinum Equity

Industrials

46.9

3.5%

Constellation Automotive

2019

TDR Capital

Business Services

44.1

3.3%

AutoStore (OB.AUTO)

2019

THL

Industrials

39.9

3.0%

Fortna

2017

THL

Industrials

39.7

3.0%

Cotiviti

2018

Veritas Capital

Healthcare

39.5

3.0%

Branded Cities Network

2017

Shamrock Capital

Communications / Media

39.3

2.9%

Business Services Company*

2017

Not Disclosed

Business Services

34.8

2.6%

BeyondTrust

2018

Francisco Partners

Technology / IT

34.6

2.6%

True Potential

2022

Cinven

Financial Services

32.3

2.4%

Monroe Engineering

2021

AEA Investors

Industrials

31.9

2.4%

Kroll

2020

Further Global / Stone Point

Financial Services

31.5

2.4%

GFL (NYSE: GFL)

2018

BC Partners

Business Services

30.9

2.3%

Marquee Brands

2014

Neuberger Berman

Consumer

29.4

2.2%

Stubhub

2020

Neuberger Berman

Consumer

26.4

2.0%

Staples

2017

Sycamore Partners

Business Services

25.8

1.9%

Engineering

2020

NB Renaissance / Bain Capital

Technology / IT

25.1

1.9%

Benecon

2024

TA Associates

Healthcare

25.0

1.9%

Viant

2018

JLL Partners

Healthcare

24.7

1.9%

Agiliti (NYSE: AGTI)

2019

THL

Healthcare

24.7

1.9%

Addison Group

2021

Trilantic Capital Partners

Business Services

23.9

1.8%

Auctane

2021

Thoma Bravo

Technology / IT

23.3

1.8%

Excelitas

2022

AEA Investors

Industrials

21.9

1.6%

Solace Systems

2016

Bridge Growth Partners

Technology / IT

20.6

1.5%

Renaissance Learning

2018

Francisco Partners

Technology / IT

20.2

1.5%

Bylight

2017

Sagewind Partners

Technology / IT

19.7

1.5%

USI

2017

KKR

Financial Services

18.4

1.4%

Exact

2019

KKR

Technology / IT

18.3

1.4%

Qpark

2017

KKR

Transportation

17.5

1.3%

Total Top 30 Investments

 

 

 

                     $950.4

71.3%


Geography

% of Portfolio

North America

74%

Europe

24%

Asia / Rest of World

2%

Total Portfolio

100%

 

 

Industry

% of Portfolio

Tech, Media & Telecom

21%

Consumer / E-commerce

22%

Industrials / Industrial Technology

18%

Business Services

12%

Financial Services

12%

Healthcare

9%

Other

5%

Energy

1%

Total Portfolio

100%

 

 

Vintage Year

% of Portfolio

2016 & Earlier

12%

2017

19%

2018

17%

2019

16%

2020

13%

2021

14%

2022

5%

2023

1%

2024

3%

Total Portfolio

100%

About NB Private Equity Partners Limited
NBPE invests in direct private equity investments alongside market leading private equity firms globally. NB Alternatives Advisers LLC (the “Investment Manager”), an indirect wholly owned subsidiary of Neuberger Berman Group LLC, is responsible for sourcing, execution and management of NBPE. The vast majority of direct investments are made with no management fee / no carried interest payable to third-party GPs, offering greater fee efficiency than other listed private equity companies. NBPE seeks capital appreciation through growth in net asset value over time while paying a bi-annual dividend.

LEI number: 213800UJH93NH8IOFQ77

About Neuberger Berman
Neuberger Berman is an employee-owned, private, independent investment manager founded in 1939 with 2,800 employees in 26 countries. The firm manages $463 billion of equities, fixed income, private equity, real estate and hedge fund portfolios for global institutions, advisors and individuals. Neuberger Berman’s investment philosophy is founded on active management, fundamental research and engaged ownership. UNPRI named the firm a Leader, a designation awarded to fewer than 1% of investment firms for excellence in environmental, social and governance practices. Neuberger Berman has been named by Pensions & Investments as the #1 or #2 Best Place to Work in Money Management for each of the last ten years (firms with more than 1,000 employees). Visit www.nb.com for more information. Data as of December 31, 2023.

This press release appears as a matter of record only and does not constitute an offer to sell or a solicitation of an offer to purchase any security. NBPE is established as a closed-end investment company domiciled in Guernsey. NBPE has received the necessary consent of the Guernsey Financial Services Commission. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. This document is not intended to constitute legal, tax or accounting advice or investment recommendations. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. Statements contained in this document that are not historical facts are based on current expectations, estimates, projections, opinions and beliefs of NBPE's investment manager. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. Additionally, this document contains "forward-looking statements." Actual events or results or the actual performance of NBPE may differ materially from those reflected or contemplated in such targets or forward-looking statements.



1 Pending realisations are subject to customary closing conditions. No assurances can be given the transactions ultimately close.


Attachment